NASDAQ: PASWPing An Biomedical Co Ltd Stock
$0.23+0.01 (+4.55%)
Updated Feb 13, 2026
PASW Price
$0.23
Fair Value Price
N/A
Market Cap
$4.76M
52 Week Low
$0.16
52 Week High
$5.40
P/E
-2.34x
P/B
0.73x
P/S
4.78x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.90M
Earnings
-$1.80M
Gross Margin
2.8%
Operating Margin
-42.1%
Profit Margin
-37.6%
Debt to Equity
0.51
Operating Cash Flow
-$903k
Beta
1.3
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PASW Overview
Ping An Biomedical Co., Ltd. engages in the provision of supply chain management services in the apparel industry delivering one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. It operates through the Yarns and Finished Garments segments. The company was founded by Yuk Yin Li and Sek Yan Ko in 2013 and is headquartered in Hong Kong.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PASW's potential to beat the market
- PASW doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important PASW news, forecast changes, insider trades & much more!
PASW News
Overview
Due Diligence Score
–
Industry Average (20)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PASW scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PASW is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PASW is good value based on its book value relative to its share price (0.73x), compared to the US Textile Manufacturing industry average (1.73x)
P/B vs Industry Valuation
PASW is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PASW due diligence checks available for Premium users.
Valuation
PASW fair value
Fair Value of PASW stock based on Discounted Cash Flow (DCF)
Price
$0.23
Fair Value
-$0.32
Undervalued by
171.33%
PASW is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PASW price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.34x
Industry
-28.15x
Market
43.92x
PASW price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.73x
Industry
1.73x
PASW is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PASW's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
PASW's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
PASW's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$9.6M
Liabilities
$3.3M
Debt to equity
0.51
PASW's short-term assets ($9.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PASW's short-term assets ($9.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PASW's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
PASW's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PASW vs Textile Stocks
Ping An Biomedical Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.